NCT04746183: AGILE (Early Phase Platform Trial for COVID-19) |
|
|
| Active, not recruiting | 1/2 | 600 | Europe, RoW | CST-2: EIDD-2801, MK-4482, Molnupiravir, CST-2: Placebo, Placebo, Nitazoxanide, VIR-7832, VIR-7831, Sotrovimab, CST-5: Placebo, Favipiravir, Lagevrio, Paxlovid, nirmatrelvir and ritonavir | University of Liverpool, University of Southampton, Liverpool School of Tropical Medicine, Liverpool University Hospitals NHS Foundation Trust, University of Cambridge | Covid19 | 12/23 | 04/24 | | |
